Toshiba America Medical Systems, Inc.
12
0
0
8
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 12 trials
100.0%
+13.5% vs industry average
8%
1 trials in Phase 3/4
13%
1 of 8 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (12)
The Value of CT-FFR Compared to CCTA or CCTA and Stress MPI in Low to Intermediate Risk ED Patients With Toshiba CT-FFR
Role: collaborator
Implementing Myocardial Computed Tomographic Perfusion in a Community Hospital Setting
Role: collaborator
Combined Non-invasive Coronary Angiography and Myocardial Perfusion Imaging Using 320 Detector Computed Tomography
Role: collaborator
Screening For Asymptomatic Obstructive Coronary Artery Disease Among High-Risk Diabetic Patients Using CT Angiography, Following Core 64
Role: collaborator
Renal Artery Contrast-Free Trial
Role: collaborator
General Investigative MRI Protocol
Role: lead
Verification of the Quantitative Accuracy of the PET/CT System Imaging Chain
Role: lead
Clinical Image Evaluation for the DREX-KL80 Imaging System
Role: lead
Safety of the PET-512MC Transesophageal Transducer
Role: lead
Safety of the PET-511BTM Transesophageal Transducer
Role: lead
Diagnostic Accuracy of Multi-Detector Spiral Computed Tomography Angiography Using 64 Detectors
Role: collaborator
Graft Patency in Beating Heart Vs. Conventional CABG Using Cardiac CT
Role: collaborator
All 12 trials loaded